NovAliX is a private small molecule drug discovery company combining excellence in medicinal and process chemistry with outstanding biophysical capabilities (supramolecular Mass Spectrometry, X-Ray crystallography, liquid- and solid state NMR).

The company is committed to advance small molecules discovery and development programs building on proprietary technologies and the multidisciplinary expertise of its scientific team. Client-oriented and results-driven solutions, excellence in science are the hallmarks of our corporate values.

NovAliX has a global footprint with clients in North America, Europe and Japan spanning major and mid-size pharmaceutical companies as well as biotechnology companies.

The Website of NovAliX and the information contained and referenced therein are for informational purposes only. Any reproduction, retransmission or other use is strictly prohibited.

Request for permission to reproduce any information contained on this Website should be addressed to NovAliX.